ClearNote Health
U of Southampton to Use ClearNote Health Test in Large-Scale Pancreatic Cancer Surveillance Study
The epigenetic test will look for signs of pancreatic cancer among adults newly diagnosed with type 2 diabetes in a trial that aims to enroll up to 15,000 participants.
The company recently published data demonstrating its platform's potential use for prediction and monitoring of immunotherapy response for patients with lung cancer.